Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › BTSG

FARALLON CAPITAL MANAGEMENT, L.L.C. position in BTSG

BRIGHTSPRING HEALTH SVCS INC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 1,732,800 shares of BTSG (BRIGHTSPRING HEALTH SVCS INC) in its Q2 2026 13F filing — a position valued at US$120.8M, representing 0.56% of its reported portfolio and ranking #32 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed BTSG holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.73M sh
Reported value held$120.85M
Portfolio Weight0.56%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s BTSG position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in BTSG in Q1 2024 at 22,000 shares (US$239K). The position peaked in Q2 2026 at 1,732,800 shares, worth US$120.8M. Across 10 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 1,732,800 shares valued at US$120.8M — an increase of 115,800 shares quarter over quarter.. Notable position changes include a 7250% increase in Q1 2026 (shares rose 64% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 22.00K $239.14K New
Q2 2024 22.00K $249.92K Hold
Q3 2024 22.00K $322.96K Hold
Q4 2024 22.00K $374.66K Hold
Q1 2025 22.00K $397.98K Hold
Q2 2025 22.00K $518.98K Hold
Q3 2025 22.00K $650.32K Hold
Q4 2025 22.00K $823.90K Hold
Q1 2026 1.62M $68.90M Add
Q2 2026 1.73M $120.85M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BTSG and 13F data

BTSG (BRIGHTSPRING HEALTH SVCS INC) is a Health Care company. 80 other funds we track also report a position in BTSG — the largest reported positions include Kohlberg Kravis Roberts & Co. L.P. (US$1.87B), FULLER & THALER ASSET MANAGEMENT, INC. (US$234.4M), Marshall Wace (US$183.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BTSG

All BTSG fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held BTSG?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed BTSG holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in BTSG?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 1.73M shares of BTSG (BRIGHTSPRING HEALTH SVCS INC), valued at $120.85M, representing 0.56% of its reported portfolio and ranking #32.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling BTSG?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in BTSG. The position peaked in Q2 2026 at 1.73M shares.

Which other funds hold BTSG?

Other major institutional holders of BTSG include Kohlberg Kravis Roberts & Co. L.P., FULLER & THALER ASSET MANAGEMENT, INC., Marshall Wace, among 80 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.